Chenodeoxycholic acid Leadiant (previously known as Chenodeoxycholic acid sigma-tau) Uniunea Europeană - română - EMA (European Medicines Agency)

chenodeoxycholic acid leadiant (previously known as chenodeoxycholic acid sigma-tau)

leadiant gmbh - chenodeoxycholic acid - xanthomatosis, cerebrotendinous; metabolism, inborn errors - terapia cu bila și cu ficatul - acidul chenodeoxycholic este indicat pentru tratamentul de erori înnăscută de sinteza acizilor primare din cauza sterol 27 fenilalaninhidroxilazei deficit (prezentarea ca cerebrotendinous xanthomatosis (ctx)) la sugari, copii şi adolescenţi în vârstă de 1 lună de la 18 ani şi adulti.

IRINOTECAN HAMELN 20 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

irinotecan hameln 20 mg/ml

haupt pharma wolfratshausen gmbh - germania - irinotecanum - conc. pt. sol. perf. - 20mg/ml - alte antineoplazice alte antineoplazice

Magnerot comprimate 500 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

magnerot comprimate 500 mg

worwag pharma gmbh&co.kg - magneziu orotas - comprimate - 500 mg

Sotagamma 80 80 mg comprimate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

sotagamma 80 80 mg comprimate

worwag pharma gmbh & co. kg - sotalolum - comprimate - 80 mg

FEMARA 2,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

femara 2,5 mg

novartis pharma gmbh - germania - letrozolum - compr. film. - 2,5mg - antihormoni inhibitori enzimatici

IOD POVIDONA YES PHARMACEUTICAL DEVELOPMENT SERVICES GMBH 7,7 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

iod povidona yes pharmaceutical development services gmbh 7,7 mg/ml

b. braun melsungen a.g. - germania - povidonum iodinatum - sol. cut./sol. bucofaringiana - 7,7mg/ml - antiseptice si dezinfectante preparate ce contin iod

IMATINIB KOANAA 100 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

imatinib koanaa 100 mg

drehm pharma gmbh - austria - imatinibum - compr. film. - 100mg - alte antineoplazice inhibitori de protein-kinaza

IMATINIB KOANAA 400 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

imatinib koanaa 400 mg

drehm pharma gmbh - austria - imatinibum - compr. film. - 400mg - alte antineoplazice inhibitori de protein-kinaza

Comirnaty Uniunea Europeană - română - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

CAPECITABINA KOANAA 150 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

capecitabina koanaa 150 mg

drehm pharma gmbh - austria - capecitabinum - compr. film. - 150mg - antimetaboliti analogi ai bazelor pirimidinice